Clinical Trial Detail

NCT ID NCT04262869
Title Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

lung non-small cell carcinoma

Therapies

Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Paclitaxel

Durvalumab

Age Groups: adult senior

No variant requirements are available.